Vector Bioscience Cambridge

Agnostic drug delivery platform for targeted delivery and controlled release

Vector employs advanced porous nano shuttles, known as metal-organic frameworks (MOFs), to revolutionize cancer treatment. Their platform allows for precision medicine and drug delivery, minimising side effects by enabling targeted and controlled release of therapeutics, from small to macromolecules, including RNAs. This approach promises to significantly improve patient outcomes.



2024 finalists

Take a look at the finalists across the four competition categories